Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Prenetics Global Limited

Market Cap 334M 288M 265M 249M 469M 31.53B 473M 3.14B 1.22B 15.48B 1.25B 1.23B 53.54B P/E 2026 *
-9.21x
P/E 2027 * -36.4x
Enterprise Value 334M 288M 265M 249M 469M 31.53B 473M 3.14B 1.22B 15.48B 1.25B 1.23B 53.54B EV / Sales 2026 *
1.66x
EV / Sales 2027 * 1.06x
Free-Float
85.39%
Yield 2026 *
-
Yield 2027 * -
1 day-3.19%
1 week+3.14%
Current month-5.90%
1 month+27.19%
3 months-4.22%
6 months+24.25%
Current year+26.06%
1 week 19.3
Extreme 19.3
22.22
1 month 14
Extreme 14
22.22
Current year 14
Extreme 14
23.63
1 year 7.18
Extreme 7.175
23.63
3 years 2.85
Extreme 2.85
23.63
5 years 2.85
Extreme 2.85
131.25
10 years 2.85
Extreme 2.85
131.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 52 01/01/2014
Chief Executive Officer 47 01/01/2014
Director of Finance/CFO 41 01/01/2018
Director TitleAgeSince
Director/Board Member 60 13/06/2024
Chairman 47 01/01/2014
Director/Board Member - 16/02/2026
Date Insider Type Main position Quantity % Market Cap.
06-15Fiscal year

Director

15,625 0.1025%
06-04Other

Director

24,004 0.1574%
05-26Free

Director

6,406 0.0420%
Change 5-day change 1-year change 3-year change Capi.($)
-3.19%+3.14%+164.38%+49.94% 345M
-2.34%-0.75%-33.10%-16.67% 158B
-3.91%-2.63%-9.32%-12.35% 104B
+2.57%+10.53%+65.35%+62.42% 56.43B
-1.55%-1.48%-5.49%+51.41% 54.76B
-2.45%-4.18%-16.67%-45.25% 40B
-1.81%-0.33% - - 31.36B
-2.64%-4.73%-12.95%-45.25% 28.23B
-1.82%-2.22%+48.39%-10.62% 23.28B
-0.18%-0.97%-14.77%-4.68% 20.41B
Average -1.72%-0.74%+20.65%+3.22% 51.71B
Weighted average by Cap. -1.91%-0.84%-6.10%-2.05%

Financials

2026 *2027 *
Net sales 201M 174M 160M 150M 283M 19.01B 285M 1.89B 737M 9.33B 756M 740M 32.27B 317M 273M 251M 236M 444M 29.88B 448M 2.98B 1.16B 14.66B 1.19B 1.16B 50.73B
Net income -51.05M -44.04M -40.49M -38.11M -71.61M -4.82B -72.21M -480M -187M -2.36B -192M -188M -8.18B -8.96M -7.73M -7.11M -6.69M -12.57M -846M -12.68M -84.22M -32.79M -415M -33.63M -32.91M -1.44B
Net Debt - -
Logo Prenetics Global Limited
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
Employees
98
Date Price Change Volume
17/06/26 19.86 $ -3.19% 148,693
16/06/26 20.51 $ -1.16% 119,227
15/06/26 20.75 $ -4.07% 128,878
12/06/26 21.63 $ +4.54% 348,612
11/06/26 20.69 $ +7.48% 330,264
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
19.86USD
Average target price
31.00USD
Spread / Average Target
+56.13%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!